These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2499445)

  • 21. Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors.
    Krueger MJ; Mazouz F; Ramsay RR; Milcent R; Singer TP
    Biochem Biophys Res Commun; 1995 Jan; 206(2):556-62. PubMed ID: 7826372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The importance of the chemical structure of monoamine oxidase inhibitors for their effect on the gamma-aminobutyric acid content of the rat brain].
    Matthies H; Popov N
    Acta Biol Med Ger; 1967; 18(5):617-24. PubMed ID: 5589667
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of various monoamine oxidase inhibitors on cholinesterase activity in the brains of white rats].
    Ganev G; Velkov V
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(4):512-5. PubMed ID: 5070019
    [No Abstract]   [Full Text] [Related]  

  • 24. Indolizine derivatives with biological activity I: N'-substituted hydrazides of indolizine-2-carboxylic acid.
    Cardellini M; Claudi F; Grifantini M; Gulini U; Martelli S
    J Pharm Sci; 1977 Feb; 66(2):259-62. PubMed ID: 839424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Pharmacological and biochemical properties of pyridylethylhydrazines and pyridylethylamines].
    Kost AN; Matrenina VL; Sidorkin VI; Smirnova AV; Shadurskiĭ KS
    Farmakol Toksikol; 1967; 30(2):178-83. PubMed ID: 4300254
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effect of tyramine and cheese on the blood pressure and their modification by DL-serine-N2-isopropylhydrazide (Ro 4-1038) on awake intact dogs].
    Gerold M
    Arzneimittelforschung; 1968 Sep; 18(9):1198-200. PubMed ID: 5755936
    [No Abstract]   [Full Text] [Related]  

  • 27. [Inhibition of respiratory proton pumps of mitochondria by Brenstead acids].
    Sharyshev AA; Dubinskaia EI; Iaguzhinskiĭ LS
    Biokhimiia; 1980 Dec; 45(12):2121-9. PubMed ID: 7248345
    [No Abstract]   [Full Text] [Related]  

  • 28. Tissue monoamine oxidase inhibitions by convulsigenic doses of hydrazines and related B6-hydrazones. SAM-TR-66-79.
    Wykes AA
    Tech Rep SAM-TR; 1966 Sep; ():1-11. PubMed ID: 5297194
    [No Abstract]   [Full Text] [Related]  

  • 29. [The importance of substrate structure in selective inhibition of mitochondrial monoamine oxidase activity by several inhibitors].
    Severina IS
    Biokhimiia; 1973; 38(3):608-15. PubMed ID: 4798599
    [No Abstract]   [Full Text] [Related]  

  • 30. Qualitative alterations in enzymatic properties of amine oxidases.
    Gorkin VZ
    Adv Biochem Psychopharmacol; 1972; 5():55-65. PubMed ID: 4626560
    [No Abstract]   [Full Text] [Related]  

  • 31. 3-Hydrazinopyridazine derivatives as inhibitors of pyridoxal-phosphate dependent enzymes.
    Buffoni F; Carpi C; Banchelli Soldaini G; Raimondi L
    Farmaco Sci; 1980 Oct; 35(10):848-55. PubMed ID: 6778712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substituted quinazolonephenoxyethylhydrazines as monoamine oxidase inhibitors.
    Parmar SS; Arora RC
    J Med Chem; 1970 Jan; 13(1):135-6. PubMed ID: 5412085
    [No Abstract]   [Full Text] [Related]  

  • 33. [The status of monoaminoxidase in myocardial, diaphragm and liver mitochondria in swine breeds of different constitutions].
    Quanz G; Dzapo V
    Dtsch Tierarztl Wochenschr; 1987; 94(7):403-6. PubMed ID: 3304940
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors.
    Hassan SY; Khattab SN; Bekhit AA; Amer A
    Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Synthesis, pharmacological properties and effect upon monoamine oxidase activity of some sydnoneimines].
    Iashunskiĭ VG; Mashkovskiĭ MD; Gorkin VZ; Kholodov LE; Al'tshuler RA; Polezhaeva AI; Verevkina IV
    Farmakol Toksikol; 1970; 33(3):297-302. PubMed ID: 5453024
    [No Abstract]   [Full Text] [Related]  

  • 36. Synthesis and monoamine oxidase inhibitory activity of some pentafluorobenzylidenes and their corresponding hydrazines.
    Aboul-Enein HY; El-Obeid HA; El-Farra AA
    Pharm Acta Helv; 1980; 55(10):282-4. PubMed ID: 7454735
    [No Abstract]   [Full Text] [Related]  

  • 37. [Amine binding with mitochondrial monoamine oxidase and the selective inhibition of enzymatic activity by pyridine derivatives].
    Severina IS; Kozlova IS
    Biokhimiia; 1973; 38(5):1076-82. PubMed ID: 4780966
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemical structure and pharmacological activity of glycine derivatives. Influence of disubstitution of the amine function of glycine esters and hydrazides.
    Rips R; Derappe C; Magnin P
    J Med Chem; 1965 Jul; 8(4):529-31. PubMed ID: 4379938
    [No Abstract]   [Full Text] [Related]  

  • 39. Isolation and characterization of a monoamine oxidase B selective inhibitor from tobacco smoke.
    Khalil AA; Davies B; Castagnoli N
    Bioorg Med Chem; 2006 May; 14(10):3392-8. PubMed ID: 16458520
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors involved in the selective inhibition of monoamine oxidase.
    Tipton KF; O'Carroll AM; Mantle TJ; Fowler CJ
    Mod Probl Pharmacopsychiatry; 1983; 19():15-30. PubMed ID: 6346064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.